Tus Pharmaceutical Group Co Ltd (000590) - Total Assets
Based on the latest financial reports, Tus Pharmaceutical Group Co Ltd (000590) holds total assets worth CN¥875.56 Million CNY (≈ $128.12 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Tus Pharmaceutical Group Co Ltd - Total Assets Trend (1995–2025)
This chart illustrates how Tus Pharmaceutical Group Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see 000590 company net worth for the company's overall valuation and market capitalisation.
Tus Pharmaceutical Group Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Tus Pharmaceutical Group Co Ltd's total assets of CN¥875.56 Million consist of 42.6% current assets and 57.4% non-current assets. Review 000590 total debt and obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 20.0% |
| Accounts Receivable | CN¥2.10 Million | 0.2% |
| Inventory | CN¥109.57 Million | 12.3% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥123.45 Million | 13.9% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (1995–2025)
This chart illustrates how Tus Pharmaceutical Group Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 000590 live share price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Tus Pharmaceutical Group Co Ltd's current assets represent 42.6% of total assets in 2025, a decrease from 60.8% in 1995.
- Cash Position: Cash and equivalents constituted 20.0% of total assets in 2025, up from 3.7% in 1995.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 13.0% of total assets, an increase from 3.0% in 1995.
- Asset Diversification: The largest asset category is intangible assets at 13.9% of total assets.
Tus Pharmaceutical Group Co Ltd Competitors by Total Assets
Key competitors of Tus Pharmaceutical Group Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Yunnan Baiyao Group Co Ltd
SHE:000538
|
China | CN¥53.34 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Harbin Gloria Pharmaceuticals
SHE:002437
|
China | CN¥3.14 Billion |
|
Jiuzhitang Co Ltd
SHE:000989
|
China | CN¥5.73 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
Tus Pharmaceutical Group Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.88 | 2.02 | 3.58 |
| Quick Ratio | 1.88 | 1.49 | 3.20 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥170.59 Million | CN¥259.28 Million | CN¥374.34 Million |
Tus Pharmaceutical Group Co Ltd - Advanced Valuation Insights
This section examines the relationship between Tus Pharmaceutical Group Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.88 |
| Latest Market Cap to Assets Ratio | 0.35 |
| Asset Growth Rate (YoY) | -12.2% |
| Total Assets | CN¥889.47 Million |
| Market Capitalization | $311.17 Million USD |
Valuation Analysis
Below Book Valuation: The market values Tus Pharmaceutical Group Co Ltd's assets below their book value (0.35x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Tus Pharmaceutical Group Co Ltd's assets decreased by 12.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Tus Pharmaceutical Group Co Ltd (1995–2025)
The table below shows the annual total assets of Tus Pharmaceutical Group Co Ltd from 1995 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥889.47 Million ≈ $130.16 Million |
-12.23% |
| 2024-12-31 | CN¥1.01 Billion ≈ $148.29 Million |
-11.96% |
| 2023-12-31 | CN¥1.15 Billion ≈ $168.45 Million |
-1.34% |
| 2022-12-31 | CN¥1.17 Billion ≈ $170.73 Million |
+20.55% |
| 2021-12-31 | CN¥967.83 Million ≈ $141.62 Million |
+8.48% |
| 2020-12-31 | CN¥892.16 Million ≈ $130.55 Million |
+5.36% |
| 2019-12-31 | CN¥846.74 Million ≈ $123.91 Million |
+3.69% |
| 2018-12-31 | CN¥816.60 Million ≈ $119.49 Million |
-6.54% |
| 2017-12-31 | CN¥873.74 Million ≈ $127.86 Million |
+38.54% |
| 2016-12-31 | CN¥630.68 Million ≈ $92.29 Million |
+7.36% |
| 2015-12-31 | CN¥587.43 Million ≈ $85.96 Million |
+0.10% |
| 2014-12-31 | CN¥586.82 Million ≈ $85.87 Million |
+6.20% |
| 2013-12-31 | CN¥552.56 Million ≈ $80.86 Million |
-21.51% |
| 2012-12-31 | CN¥704.02 Million ≈ $103.02 Million |
+16.86% |
| 2011-12-31 | CN¥602.45 Million ≈ $88.16 Million |
+5.93% |
| 2010-12-31 | CN¥568.73 Million ≈ $83.22 Million |
+10.15% |
| 2009-12-31 | CN¥516.33 Million ≈ $75.56 Million |
-9.62% |
| 2008-12-31 | CN¥571.31 Million ≈ $83.60 Million |
+4.14% |
| 2007-12-31 | CN¥548.58 Million ≈ $80.27 Million |
+0.59% |
| 2006-12-31 | CN¥545.36 Million ≈ $79.80 Million |
-17.94% |
| 2005-12-31 | CN¥664.58 Million ≈ $97.25 Million |
-1.78% |
| 2004-12-31 | CN¥676.63 Million ≈ $99.01 Million |
-1.25% |
| 2003-12-31 | CN¥685.16 Million ≈ $100.26 Million |
-5.48% |
| 2002-12-31 | CN¥724.86 Million ≈ $106.07 Million |
+4.29% |
| 2001-12-31 | CN¥695.05 Million ≈ $101.71 Million |
+9.24% |
| 2000-12-31 | CN¥636.26 Million ≈ $93.10 Million |
+6.60% |
| 1999-12-31 | CN¥596.86 Million ≈ $87.34 Million |
+47.61% |
| 1998-12-31 | CN¥404.35 Million ≈ $59.17 Million |
+8.36% |
| 1997-12-31 | CN¥373.15 Million ≈ $54.60 Million |
+99.06% |
| 1996-12-31 | CN¥187.46 Million ≈ $27.43 Million |
+32.90% |
| 1995-12-31 | CN¥141.06 Million ≈ $20.64 Million |
-- |
About Tus Pharmaceutical Group Co Ltd
Guhan Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells traditional Chinese medicines, chemical drugs, and health food under the Guhan brand in China. It operates through the Pharmaceutical and Health Product Manufacturing and Sales Business, Active Pharmaceutical Ingredient (API) Manufacturing and Sales Business, and Other Business segments. The company offer… Read more